Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Prostatic Diseases × Prostate-Specific Antigen × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1 Prostatic Diseases 1 Neoplasms 1

Interventions

darolutamide 2 olaparib 1 gedatolisib 1 gallium 68 PSMA-11 1 Radiotherapy 1 Prostate-Specific Antigen 1 Pluvicto 1 Nivolumab 1 Lutetium-177 1 Lutetium 1 Cryotherapy 1 Brachytherapy 1 Androgen Antagonists 1 Abiraterone Acetate 1 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 1 (225)Ac-PSMA-617 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00853710 2025-11-20

Test Semiquantitative Prostate Specific Antigen (PSA)

Institut Curie

Phase NA Completed

Neoplasms, Prostatic Diseases, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡